# A Study of Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]AZD4144

> **NCT07518459** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **AstraZeneca** · enrollment: 8 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** [14C]AZD4144 Solution for Infusion
- **DRUG:** [14C]AZD4144 Oral Solution

## Key facts

- **NCT ID:** NCT07518459
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-02-11
- **Primary completion:** 2026-05-28
- **Final completion:** 2026-05-28
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07518459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07518459, "A Study of Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]AZD4144". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07518459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*